Navigation Links
New Survey Emphasizes Value of Biopharmaceutical Company Engagement With Healthcare Providers
Date:3/29/2011

WASHINGTON, March 29, 2011 /PRNewswire-USNewswire/ -- Nearly eight out of 10 physicians view pharmaceutical research companies and their sales representatives as useful sources of information on prescription medicines, according to a survey released today by KRC Research.

The telephone survey of more than 500 American Medical Association members found that physicians consider a range of sources useful for staying informed about medicines. In addition to biopharmaceutical representatives and company-sponsored peer education programs, respondents also rated continuing medical education courses, peer-reviewed medical journals, and their fellow physicians as useful sources of information.

The survey also found that physicians consider a broad range of factors in making their prescribing decisions, with almost all respondents relying on their clinical knowledge and experience as well as a patient's response to a particular medicine. More than 80 percent reported that they take into consideration a patient's insurance factors, such as formulary and prior authorization requirements, with just under 70 percent using information provided by biopharmaceutical research company representatives.

Pharmaceutical Research and Manufacturers of America President and CEO John J. Castellani said of the survey findings, "What is clear from the results of the survey is that physicians review and integrate information from many sources in order to stay informed about medicines. This helps them make the most informed treatment decisions possible."

The survey, which was supported by PhRMA, also looked closely at how physician respondents view their interactions with biopharmaceutical company representatives.

For example, more than 90 percent responded that interactions with representatives allow them to learn about new indications for approved medicines, potential side effects of medicines, and both emerging benefits and risks of medicines.

In addition, 84 percent of physicians said that interactions with representatives allow them the opportunity to provide feedback to a pharmaceutical company about their experiences with a specific medicine.

Large majorities also found information from company representatives to be up-to-date and timely (94 percent), useful (92 percent), and reliable (84 percent).

The survey also included several questions about company-sponsored peer education programs, in which physicians present FDA-approved scientific information to their peers on behalf of biopharmaceutical research companies. Nearly nine in 10 of physicians who reported attending these programs said the information was up-to-date, useful and reliable.

According to the survey findings, these programs are particularly important to physicians in rural areas, who may find it difficult to attend professional conferences or continuing medical education courses: 86 percent of physicians in rural areas are likely to attend peer education programs. Overall, 76 percent of responding physicians have attended them.

Physicians attending peer education programs reported gaining a range of information, including: improved clinical knowledge (98 percent), potential side effects of medicines (97 percent), new uses of medicines (97 percent), the range of treatment options (97 percent), and emerging drug risks (95 percent). Importantly, 94 percent said the programs strengthened their ability to care for patients.

"Peer education programs allow physicians to have important dialogues with their expert colleagues. This sharing of information ultimately benefits the patients they treat," said PhRMA's Castellani.

The data from the survey emphasizes the value of interactions between biopharmaceutical company representatives and healthcare providers. This value is reinforced by PhRMA's Code on Interactions with Healthcare Professionals, which seeks to ensure that biopharmaceutical company engagement with providers is professional, ethical, and educational – and, ultimately, helps to give physicians some of the tools they need to give their patients the best care possible. The Code, which was updated and strengthened in 2009, is available here.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $49.4 billion in 2010 in discovering and developing new medicines. Industry-wide research and investment reached a record $67.4 billion in 2010. 

Find PhRMA Online:


For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Nationwide Survey Identifies Need for Increased Dialogue Between Gastroesophageal Reflux Disease or Frequent Heartburn Sufferers and Health Care Providers
2. National Nasal Allergy Survey Reveals Unmet Needs Still Exist Among Patients Living With Allergic Rhinitis
3. Survey Sampling International Names Chris DeAngelis to Head New SSI Health
4. Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011
5. Thats Nice LLC Launches Nice Insight Marketing Intelligence for CRAMs With Its Pharma & Biotech Outsourcing Survey
6. Survey Finds Patients Oppose Prescription Mandate for OTC Medicines Containing Pseudoephedrine
7. Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available
8. On Average, 55 Percent of Surveyed U.S. Asthma Patients Say They Are Likely to Request a Switch to a Drug With Efficacy Comparable to Their Current Medication but Which is Dosed Just Once a Day
9. Reportlinker Adds Healthcare Reform: 2010 Medical Device Industry Perceptions Survey
10. A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
11. Activity Against Key Drug-Resistant Pathogens is the Most Important Attribute Influencing Surveyed Physicians Antibiotic Selection for Nosocomial Pneumonia in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... 8, 2017 ... Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September 18 th .The ... free MRI brain scans to the public.Where:  BTF,s ... at 501 K Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris ... focused on fulfilling the promise of precision medicine, ... validate the benefits of its molecular profiling approach ... utilized comprehensive genomic profiling plus (CGP+) with Caris ... patient,s tumor on a molecular level, leading to ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... ... Trusted debt-reduction firm CreditAssociates, LLC has announced two important milestones. To date, the ... in resolved debt for its clients. , Credit card debt, unpaid hospital bills, department ... settled by the company. With more than a decade of combined service to the ...
(Date:9/19/2017)... ... 19, 2017 , ... The American College of Lifestyle ... recently formed Corporate Roundtable, a group of individuals and organizations whose collective vision ... Canyon Ranch is a unique collection of lifestyle-based immersion vacation settings and programs ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... unveiled the MirixaPro 6.0 platform. As the industry’s leading Medication Therapy Management ... delivered. Based on industry research and market feedback, the latest version of ...
(Date:9/19/2017)... ... 2017 , ... Driving Dynamics Inc., announced today it has been selected as ... part of its mission to continually monitor the training marketplace for the best providers ... 20 Health and Safety Training Companies list was based on the following criteria: , ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... supplement developed by a neurosurgeon, has received a big bump in sales ... Brain Booster is currently available on the Wal-Mart Stores-owned Jet.com, StackedNutrtion.com, RonnieColemanNutrition.com, ...
Breaking Medicine News(10 mins):